Pure Global

User Evaluation of BGM VGM77 - Trial NCT06037512

Access comprehensive clinical trial information for NCT06037512 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Completed. The study focuses on Diabetes. Target enrollment is 106 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06037512
Completed
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT06037512
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
User Evaluation of BGM VGM77
Evaluierung Des Blutglukose Monitoring Systems VGM77 Der Firma Beurer GmbH gemรครŸ DIN EN ISO 15197:2015

Study Focus

Diabetes

subject

Interventional

diagnostic test

Sponsor & Location

Institut fur Diabetes Karlsburg GmbH

Karlsburg, Germany

Timeline & Enrollment

N/A

Apr 13, 2023

Jun 15, 2023

106 participants

Primary Outcome

Analysis of system accuracy based on DIN EN ISO 15197

Summary

Performance Evaluation by the User of the Blood Glucose Monitoring System VGM77Compliant with
 DIN EN ISO 15197:2015

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus without complications

Data Source

ClinicalTrials.gov

NCT06037512

Non-Device Trial